LGND
NASDAQ · Pharmaceuticals
Ligand Pharmaceuticals
$313.58
+7.38 (+2.41%)
Performance
1D
-0.18%
1W
+0.02%
1M
+0.79%
3M
+6.93%
6M
+43.20%
1Y
+49.83%
YTD
+64.95%
Open$308.87
Previous Close$306.20
Day High$314.93
Day Low$307.14
52W High$326.63
52W Low$175.89
Volume—
Avg Volume250.5K
Market Cap5.98B
P/E Ratio30.33
EPS$9.40
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$299.49
Above
SMA 200
$255.99
Above
RSI (14)
53.9
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
17 analysts
Price Target
-89.9% upside
Current
$313.58
$313.58
Target
$31.56
$31.56
$18.80
$31.56 avg
$35.41
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 258.03M | 232.52M | 944.72M |
| Net Income | 119.78M | 97.15M | 258.92M |
| Profit Margin | 46.4% | 44.1% | 27.4% |
| EBITDA | 70.94M | 60.73M | 346.84M |
| Free Cash Flow | — | — | 167.31M |
| Rev Growth | +11.0% | +11.0% | +8.5% |
| Debt/Equity | 0.44 | 0.44 | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,422.11 | +0.72% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $281.96 | -0.05% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.82 | -1.30% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.25 | +0.07% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.20 | +0.10% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $81.95 | -0.45% | 12.8 | 33.59B |